Wonder drug Enzalutamide may help to cure both prostate cancer & breast cancer
Enzalutamide (marketed as Xtandi and formerly known as MDV3100) is an androgen receptor antagonist drug developed by the pharmaceutical company Medivation for the treatment of metastatic castration-resistant prostate cancer. Medivation has reported up to an 89% decrease in prostate specific …
Wonder drug Enzalutamide may help to cure both prostate cancer & breast cancer Read More